Pages that link to "Q28379121"
Jump to navigation
Jump to search
The following pages link to Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels (Q28379121):
Displaying 50 items.
- Structural determinants of drugs acting on the Nav1.8 channel (Q24644825) (← links)
- The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness (Q24657946) (← links)
- Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action (Q24671796) (← links)
- Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921 (Q24672256) (← links)
- State-dependent trapping of flecainide in the cardiac sodium channel (Q24677114) (← links)
- Molecular targets for antiepileptic drug development (Q24683346) (← links)
- The hitchhiker's guide to the voltage-gated sodium channel galaxy (Q26771787) (← links)
- Voltage-gated sodium channel-associated proteins and alternative mechanisms of inactivation and block (Q26991734) (← links)
- Ion channels as drug targets in central nervous system disorders (Q27004533) (← links)
- The crystal structure of a voltage-gated sodium channel (Q27670752) (← links)
- Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism (Q27683885) (← links)
- Atom-by-atom engineering of voltage-gated ion channels: magnified insights into function and pharmacology (Q28081786) (← links)
- Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels (Q28082803) (← links)
- The neurobiology of antiepileptic drugs (Q28267900) (← links)
- Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet (Q28272457) (← links)
- A structural basis for drug-induced long QT syndrome (Q28344808) (← links)
- Ion selectivity filter regulates local anesthetic inhibition of G-protein-gated inwardly rectifying K+ channels (Q28346279) (← links)
- Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels (Q28365230) (← links)
- Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo (Q28365414) (← links)
- Interaction of batrachotoxin with the local anesthetic receptor site in transmembrane segment IVS6 of the voltage-gated sodium channel (Q28369249) (← links)
- Locating the route of entry and binding sites of benzocaine and phenytoin in a bacterial voltage gated sodium channel (Q28540363) (← links)
- Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine (Q28548133) (← links)
- A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG (Q28553727) (← links)
- A Molecular Switch between the Outer and the Inner Vestibules of the Voltage-gated Na+ Channel (Q28579256) (← links)
- Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release (Q28601095) (← links)
- Structure and function of voltage-gated sodium channels at atomic resolution (Q29030031) (← links)
- Understanding Sodium Channel Function and Modulation Using Atomistic Simulations of Bacterial Channel Structures. (Q30392501) (← links)
- Synthesis and evaluation of hermitamides A and B as human voltage-gated sodium channel blockers (Q30425968) (← links)
- Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore (Q30433313) (← links)
- A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profile (Q30441260) (← links)
- Spectroscopic evidence for a preferential location of lidocaine inside phospholipid bilayers. (Q30743373) (← links)
- Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data (Q31136281) (← links)
- Molecular and kinetic determinants of local anaesthetic action on sodium channels (Q33537113) (← links)
- Sodium channel selectivity filter regulates antiarrhythmic drug binding (Q33748954) (← links)
- Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist (Q33807882) (← links)
- Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers (Q33812750) (← links)
- Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior (Q33878908) (← links)
- Voltage-gated sodium channels as therapeutic targets (Q33925684) (← links)
- Antiarrhythmics--from cell to clinic: past, present, and future (Q33947683) (← links)
- Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life. (Q34044585) (← links)
- Molecular biology of sodium channels and their role in cardiac arrhythmias (Q34175659) (← links)
- Tetrodotoxin (TTX) as a therapeutic agent for pain. (Q34260913) (← links)
- Voltage-gated sodium channels at 60: structure, function and pathophysiology (Q34265707) (← links)
- The mechanisms of action of commonly used antiepileptic drugs (Q34305846) (← links)
- Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore (Q34310101) (← links)
- Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels. (Q34310798) (← links)
- Investigating the size and dynamics of voltage-gated sodium channel fenestrations (Q34373996) (← links)
- A revised view of cardiac sodium channel "blockade" in the long-QT syndrome (Q34432684) (← links)
- Dampening of hyperexcitability in CA1 pyramidal neurons by polyunsaturated fatty acids acting on voltage-gated ion channels (Q34437887) (← links)
- Multiple modes of ryanodine receptor 2 inhibition by flecainide. (Q34441392) (← links)